Market Tracker

10/23 5:16pm ET

Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

41.40
Delayed Data
As of 4:00pm ET
 -0.45 / -1.08%
Today’s Change
17.25
Today|||52-Week Range
50.05
+63.96%
Year-to-Date
No recent news for Supernus Pharmaceuticals Inc.

Today’s Trading

Previous close41.85
Today’s open41.85
Day’s range40.95 - 42.05
Volume249,387
Average volume (3 months)688,734
Market cap$2.1B
Dividend yield--
Data as of 4:00pm ET, 10/23/2017

Growth & Valuation

Earnings growth (last year)+528.57%
Earnings growth (this year)-40.58%
Earnings growth (next 5 years)+28.00%
Revenue growth (last year)+48.87%
P/E ratio20.7
Price/Sales6.07
Price/Book10.91

Competitors

 Today’s
change
Today’s
% change
FOLDAmicus Therapeutics ...-0.32-2.35%
PRTAProthena Corporation...+0.04+0.07%
IRWDIronwood Pharmaceuti...-0.50-3.33%
HZNPHorizon Pharma PLC-0.23-1.63%
Data as of 4:00pm ET, 10/23/2017

Financials

Next reporting dateNovember 7, 2017
EPS forecast (this quarter)$0.27
Annual revenue (last year)$215.0M
Annual profit (last year)$91.2M
Net profit margin42.43%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, Secretary &
Director
Jack A. Khattar
Chief Financial Officer &
Vice President
Gregory S. Patrick
Corporate headquarters
Rockville, Maryland

Forecasts